文献速递角膜与眼表疾病青光眼

青光眼患者角膜上皮树突状细胞的活体分布研究

In Vivo Distribution of Corneal Epithelial Dendritic Cells in Patients With Glaucoma.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2016-01-01

本研究采用活体共聚焦显微镜评估药物控制良好的青光眼患者全角膜树突状细胞分布、形态与密度,并与干眼患者及健康对照比较。结果显示青光眼组和干眼组树突状细胞密度均高于对照,用药≥2种组高于单药组,且树突状细胞密度与角膜染色和OSDI显著相关。

要点

  • 药物控制良好的青光眼患者全角膜树突状细胞增多,以角膜缘密度更高。
  • 使用≥2种降眼压药物者树突状细胞密度高于单药使用者。
  • 单药组中使用含防腐剂药物者树突状细胞密度高于使用无防腐剂药物者。

核心结论

  • 药物控制良好的青光眼患者全角膜树突状细胞增多,以角膜缘密度更高,这些改变可能参与青光眼相关眼表疾病的发生。

研究设计与样本

  • 研究纳入50例药物控制良好的青光眼患者、15例干眼患者和15名健康对照者,采用活体共聚焦显微镜评估角膜缘和中央角膜树突状细胞密度、形态与分布。

主要发现

  • 树突状细胞在角膜缘的密度显著高于中央角膜,两组青光眼患者均如此。
  • 角膜缘树突状细胞在对照、组1、组2和干眼组中分别见于86.7%、89.7%、90.4%和93.3%的眼。
  • 中央角膜树突状细胞在对照、组1、组2和干眼组中分别见于26.6%、75.9%、80.9%和86.6%的眼。
  • 树突状细胞密度在青光眼组和干眼组均高于对照组(P < 0.001)。
  • 组2和干眼组的树突状细胞密度显著高于组1(P < 0.05);组1中含防腐剂药物者树突状细胞密度高于无防腐剂药物者(P < 0.05);干眼组树突状细胞密度高于组2(P < 0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate dendritic cell (DC) distribution, morphology, and DC density in the entire cornea of medically controlled glaucoma patients (MCGP), using in vivo confocal microscopy (IVCM). METHODS: Fifty MCGP were enrolled, 15 patients with dry eye, and 15 healthy subjects served as controls. Patients were asked to complete the Ocular Surface Disease Index (OSDI) questionnaire and then underwent tear film break-up time (BUT), corneal staining, and Schirmer test (ST) I and then IVCM. In vivo confocal microscopy evaluated the limbal and central DC density, the DCs morphology and distribution. Relationships among DC density, OSDI score, and corneal staining were analyzed. RESULTS: Medically controlled glaucoma patients were divided into 2 groups; group 1 (29 eyes) was tested with one drug; group 2 (21 eyes) was tested with ≥2 drugs. Dendritic cells were significantly higher at limbus than at central cornea in both groups. Limbal DCs were found in the 86.7%, 89.7%, 90.4%, and 93.3% of eyes in controls, groups 1 and 2, and DED; central corneal DCs were found in the 26.6%, 75.9%, 80.9%, and 86.6% of eyes in controls, groups 1 and 2, and DED. Dendritic cell density was higher in glaucoma groups and DED than in controls (P < 0.001). Group 2 and DED presented DC density significantly higher compared with group 1 (P < 0.05). In group 1 DC density was higher in patients taking preserved drugs than in those taking preservative-free drugs (P < 0.05). Dendritic cell density was higher in DED than in group 2 (P < 0.05). Dendritic cell density significantly correlated with corneal staining and OSDI (P < 0.001). CONCLUSIONS: Dendritic cells increase in the entire cornea of MCGP, with a higher density at limbus. These modifications may take part in the induction of the glaucoma-related ocular surface disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Mastropasqua R, Agnifili L, Fasanella V, et al. In Vivo Distribution of Corneal Epithelial Dendritic Cells in Patients With Glaucoma. Invest Ophthalmol Vis Sci. 2016. PMID: 27820631. doi:10.1167/iovs.16-20333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。